Douglas Whittington

Douglas Whittington has extensive work experience in the field of structural biology. Douglas began their career at the University of Pennsylvania as a Postdoctoral Fellow from September 2000 to December 2003. Douglas then joined Amgen in January 2004 as a Scientist and progressed to become a Senior Scientist from March 2007 to March 2012. Douglas further advanced to the position of Principal Scientist from March 2012 to January 2017. Since January 2017, Douglas has been working at Tango Therapeutics, initially as the Director of Structural Biology until June 2021, and currently as the Senior Director of Structural Biology.

Douglas Whittington completed their B.S. in Chemistry at the University of Michigan from 1990 to 1994. Douglas then pursued a Doctor of Philosophy (Ph.D.) in Chemistry at the Massachusetts Institute of Technology from 1994 to 2000.